Otolaryngological symptoms associated with positive RT-PCR SARS-CoV-2 infection: a case-control study in Colombia
Article Sidebar
Main Article Content
Abstract
Introduction: Otolaryngological disorders in COVID-19 patients have drawn attention worldwide. However, there is still no consensus regarding the prevalence, severity or recovery of these disorders. This study aimed to assess the association between otolaryngological symptoms and SARS-CoV-2 positivity confirmed by RT-PCR, as well as the severity, duration, and recovery of these Introduction: Otolaryngological disorders in COVID-19 patients have drawn at[1]tention worldwide. However, there is still no consensus regarding the prevalence, severity or recovery of these disorders. This study aimed to assess the association between otolaryngological symptoms and SARS-CoV-2 positivity confirmed by RT-PCR, as well as the severity, duration, and recovery of these symptoms in pa[1]tients receiving care at Fundación Santa Fe de Bogotá, a COVID-19 referral hospital in Bogotá, Colombia. Methods: Observational, analytic, prospective, case-control study conducted between October 9, 2020, and January 14, 2021. Cases included adults who tested positive for SARS-CoV-2 by reverse transcription-polymerase chain reaction (RT-PCR). Cases were matched in a 2:1 ratio with randomly selected symptomatic adults with a negative test, or patients awaiting surgery. Results: Of 10004 patients tested for SARS-CoV-2, 130 cases and 253 controls were included. The mean age was 41.8 years (standard deviation [SD]: 16.3). The otolaryngological symptoms associated with SARS-CoV-2 positivity were anosmia/hyposmia (adjus[1]ted odds ratio [aOR]: 5.82; 95% confidence interval [CI]: 1.92-17.68), dysgeusia/ hypogeusia (aOR: 9.09; 95% CI: 2.86-28.92), and dry cough (aOR: 3.18; 95% CI: 1.56-6.48). The median duration of anosmia/hyposmia and dysgeusia/hypogeusia in SARS-CoV-2 positive patients was 14.5
Article Details
Section
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Este artículo es publicado por la Revista Acta de Otorrinolaringología & Cirugía de Cabeza y Cuello.
Este es un artículo de acceso abierto, distribuido bajo los términos de la LicenciaCreativeCommons Atribución-CompartirIgual 4.0 Internacional.( http://creativecommons.org/licenses/by-sa/4.0/), que permite el uso no comercial, distribución y reproducción en cualquier medio, siempre que la obra original sea debidamente citada.
eISSN: 2539-0856
ISSN: 0120-8411
How to Cite
References
1. Mayo-Yáñez M, Palacios-García JM, Calvo-Henríquez C, Ayad T, Saydy N, León X, et al. COVID-19 Pandemic and its Impact on the Management of Head and Neck Cancer in the Spanish Healthcare System. Int Arch Otorhinolaryngol. 2021;25(4):e610–5. 10.1055/s-0041-1736425
2. Demombynes G. COVID-19 Age-Mortality Curves are Flatter in Developing Countries. Washington DC: World Bank; 2020. p. 1-31. doi: 10.1596/1813-9450-9313
3. Brandão Neto D, Pinna F de R. COVID-19 and Anosmia: Remaining Gaps to Knowledge. Int Arch Otorhinolaryngol. 2021;25(4):e479-80. doi: 10.1055/s-0041-1736563
4. Borges do Nascimento IJ, Cacic N, Abdulazeem HM, von Groote TC, Jayarajah U, Weerasekara I, et al. Novel Coronavirus Infection (COVID-19) in Humans: A Scoping
Review and Meta-Analysis. J Clin Med. 2020;9(4):941. doi: 10.3390/jcm9040941
5. Miyake MM, Anselmo-Lima WT. Monitoring of cases of anosmia may help control the COVID-19 pandemic. Braz J Otorhinolaryngol. 2021;87(4):377-78. doi: 10.1016/j. bjorl.2021.02.001
6. Lechien JR, Chiesa-Estomba CM, Vaira LA, De Riu G, Cammaroto G, Chekkoury-Idrissi Y, et al. Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients. Eur Arch Otorhinolaryngol. 2021;278(8):2851-859. doi: 10.1007/s00405-020-06548-w
7. Ozçelik Korkmaz M, Egilmez OK, Ozçelik MA, Guven M. Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection. Eur Arch Otorhinolaryngol.
2021;278(5):1675-685. doi: 10.1007/s00405-020-06396-8
8. Kapoor S, Gupta A, Saidha PK. Ear, Nose, and Throat Practice Guidelines: An Update for COVID-19. Int Arch Otorhinolaryngol. 2021;25(4):e621-e627. doi: 10.1055/s-0041-1736424
9. Carrillo-Larco RM, Altez-Fernandez C. Anosmia and dysgeusia in COVID-19: A systematic review. Wellcome Open Res. 2020;5:94. doi: 10.12688/wellcomeopenres.15917.1
10. Machin D, Campbell M, Tan S, Tan S-H. Comparing Two Independent Groups for Binary Data. In: Sample Size Tables for Clinical Studies. Oxford, UK: Wiley-Blackwell; 2011. p. 30-41. doi: 10.1002/9781444300710.ch3
11. Whitcroft KL, Hummel T. Olfactory Dysfunction in COVID-19: Diagnosis and Management. JAMA. 2020;323(24):2512-514. doi: 10.1001/jama.2020.8391
12. Lechien JR, Chiesa-Estomba CM, Place S, Van Laethem Y, Cabaraux P, Mat Q, et al. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate
coronavirus disease 2019. J Intern Med. 2020;288(3):335-44. doi: 10.1111/joim.13089
13. Dicpinigaitis PV, Canning BJ. Is There (Will There Be) a PostCOVID-19 Chronic Cough? Lung. 2020;198(6):863-65. doi: 10.1007/s00408-020-00406-6
14. Saniasiaya J, Islam MA, Abdullah B. Prevalence of Olfactory Dysfunction in Coronavirus Disease 2019 (COVID-19): A Metaanalysis of 27,492 Patients. Laryngoscope. 2021;131(4):865-
78. doi: 10.1002/lary.29286
15. Bagheri SHR, Asghari AM, Farhadi M, Shamshiri AR, Kabir A, Kamrava SK, et al. Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak. medRxiv. 2020;2020.03.23.20041889. doi: 10.1101/2020.03.23.20041889
16. Lee Y, Min P, Lee S, Kim SW. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients. J KoreaMed Sci. 2020;35(18):e174. doi: 10.3346/jkms.2020.35.e174
17. Patel ZM. Olfactory Loss and Olfactory Training. JAMA Otolaryngol Head Neck Surg. 2021;147(9):840. doi: 10.1001/jamaoto.2021.1507
18. Gengler I, Wang JC, Speth MM, Sedaghat AR. Sinonasal pathophysiology of SARS-CoV-2 and COVID-19: A systematic review of the current evidence. Laryngoscope Investig
Otolaryngol. 2020;5(3):354-59. doi: 10.1002/lio2.384
19. Speth MM, Singer-Cornelius T, Oberle M, Gengler I, Brockmeier SJ, Sedaghat AR. Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing,
and Associated Characteristics. Otolaryngol Head Neck Surg. 2020;163(1):114-20. doi: 10.1177/0194599820929185
20. Naeini AS, Karimi-Galougahi M, Raad N, Ghorbani J, Taraghi A, Haseli S, et al. Paranasal sinuses computed tomography findings in anosmia of COVID-19. Am J Otolaryngol.
2020;41(6):102636. doi: 10.1016/j.amjoto.2020.102636
21. Naunheim MR, Zhou AS, Puka E, Franco RA Jr, Carroll TL, Teng SEet al. Laryngeal complications of COVID-19. Laryngoscope Investig Otolaryngol. 2020;5(6):1117-124. doi:
10.1002/lio2.484
22. Maharaj S, Bello Alvarez M, Mungul S, Hari K. Otologic dysfunction in patients with COVID-19: A systematic review. Laryngoscope Investig Otolaryngol. 2020;5(6):1192-196. doi:
10.1002/lio2.498
23. Almufarrij I, Uus K, Munro KJ. Does coronavirus affect the audio-vestibular system? A rapid systematic review. Int J Audiol. 2020;59(7):487-91. doi: 10.1080/14992027.2020.1776406
24. Sriwijitalai W, Wiwanitkit V. Hearing loss and COVID-19: A note. Am J Otolaryngol. 2020;41(3):102473. doi: 10.1016/j.amjoto.2020.102473
25. Kilic O, Kalcioglu MT, Cag Y, Tuysuz O, Pektas E, Caskurlu H, et al. Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARSCOV-2 in the etiology of sudden sensorineural hearing loss. Int J Infect Dis. 2020;97:208-11. doi: 10.1016/j.ijid.2020.06.023
26. Fidan V. New type of corona virus induced acute otitis media in adult. Am J Otolaryngol. 2020;41(3):102487. doi: 10.1016/j.amjoto.2020.102487
27. Karimi-Galougahi M, Naeini AS, Raad N, Mikaniki N, Ghorbani J. Vertigo and hearing loss during the COVID-19 pandemic - is there an association? Acta Otorhinolaryngol Ital.
2020;40(6):463-65. doi: 10.14639/0392-100X-N0820
28. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-06. doi: 10.1016/
S0140-6736(20)30183-5
29. House T, Keeling MJ. Household structure and infectious disease transmission. Epidemiol Infect. 2009;137(5):654-61. doi: 10.1017/S0950268808001416
30. Phucharoen C, Sangkaew N, Stosic K. The characteristics of COVID-19 transmission from case to high-risk contact, a statistical analysis from contact tracing data. EClinicalMedicine. 2020;27:100543. doi: 10.1016/j.eclinm.2020.100543
31. Sackett DL. Bias in analytic research. J Chronic Dis. 1979;32(1-2):51-63. doi: 10.1016/0021-9681(79)90012-2
32. Manterola C, Otzen T. Bias in Clinical Research. Int J Morphol. 2015;33(3):1156-64. doi: 10.4067/S0717-95022015000300056
33. Böger B, Fachi MM, Vilhena RO, Cobre AF, Tonin FS, Pontarolo R. Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19. Am J Infect Control. 2021;49(1):21-29. doi: 10.1016/j.ajic.2020.07.011